Join us on Wednesday, February 7 at 3pm (EST) to learn the latest information on this type of amyloidosis from Mathew S. Maurer, MD. The webinar will define cardiac amyloidosis and focus on wild type transthyretin cardiac amyloidosis (ATTRwt).
A description of the process of protein formation will be reviewed and how this process can go array leading to cardiac amyloidosis. Names for ATTRwt will be delineated, as well as the epidemiology and common symptoms and signs in affected patients. Finally, we will review methods employed to make a diagnosis as well as emerging treatment strategies.
Save the date for this informative webinar – you will have a chance to have your question personally answered by Dr. Maurer during the Q & A at the end of his presentation.